Volume 24, Number 4—April 2018
Research Letter
Chlamydia trachomatis in Cervical Lymph Node of Man with Lymphogranuloma Venereum, Croatia, 20141
Table
Reference | Patient age, y/sex | Clinical presentation | Method of laboratory conformation | Therapy/duration |
---|---|---|---|---|
Andrada et al. (4) | 30/M | Mouth ulcer, weight loss, cervical lymphadenopathy | Serologic analysis | Tetracycline/5 wk |
Thorsteinsson et al. (3) | 31/M | Fever, supraclavicular, axillar, retroperitoneal, and cervical lymphadenopathy | Serologic analysis | Tetracycline/4 wk |
Watson et al. (6) | 19/F | Sore throat, tonsillitis, arthritis, erythema nodosum, cervical lymphadenopathy | Serologic analysis | Phenoxymethylpenicillin, indomethacin, erythromycin† |
Albay and Mathison (5) | 18/F | Fever, cervical lymphadenopathy | Serologic analysis | Ampicillin/sulbactam, doxycycline† |
Tchernev et al. (8) | 36/M | Facial skin lesions, cervical and axillary lymphadenopathy | NAAT: Chlamydia trachomatis DNA in skin lesions and serologic analysis | Surgical excision of cervical lymph nodes; pentamidine and doxycycline/3 wk |
Dosekun et al. (4) | 32/M | Sore throat, cervical lymphadenopathy, odynophagia, mouth ulcer, proctitis, cervical lymphadenopathy | NAAT: LGV-specific DNA in pharyngeal swab specimen | Amoxicillin/1 wk, doxycycline/1 wk |
Dosekun et al. (4) | 27/M | Sore throat, cervical lymphadenopathy, odynophagia, mouth ulcer, proctitis, cervical lymphadenopathy | NAAT: LGV-specific DNA in pharyngeal and rectal swab specimens | Azithromycin/1 g, doxycycline/2 wk |
This study | 48/M | Fever, cervical lymphadenopathy, proctitis | NAAT: LGV-specific DNA in cervical lymph node sample obtained by fine-needle aspirate; serologic analysis | Ceftriaxone/5 d, doxycycline/6 wk |
*LGV, lymphogranuloma venereum; NAAT, nucleic acid amplification test.
†Duration of therapy not reported.
References
- de Vrieze NH, de Vries HJ. Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review. Expert Rev Anti Infect Ther. 2014;12:697–704. DOIPubMedGoogle Scholar
- Matičič M, Klavs I, Videčnik Zorman J, Vidmar Vovko D, Kogoj R, Keše D. Confirmed inguinal lymphogranuloma venereum genovar L2c in a man who had sex with men, Slovenia, 2015. Euro Surveill. 2016;21:2–5. DOIPubMedGoogle Scholar
- Thorsteinsson SB, Musher DM, Min KW, Gyorkey F. Lymphogranuloma venereum. A cause of cervical lymphadenopathy. JAMA. 1976;235:1882. DOIPubMedGoogle Scholar
- Dosekun O, Edmonds S, Stockwell S, French P, White JA. Lymphogranuloma venereum detected from the pharynx in four London men who have sex with men. Int J STD AIDS. 2013;24:495–6. DOIPubMedGoogle Scholar
- Albay DT, Mathisen GE. Head and neck manifestations of lymphogranuloma venereum. Ear Nose Throat J. 2008;87:478–80.PubMedGoogle Scholar
- Watson DJ, Parker AJ, Macleod TI. Lymphogranuloma venereum of the tonsil. J Laryngol Otol. 1990;104:331–2. DOIPubMedGoogle Scholar
- Andrada MT, Dhar JK, Wilde H. Oral lymphogranuloma venereum and cervical lymphadenopathy. Case report. Mil Med. 1974;139:99–101.PubMedGoogle Scholar
- Tchernev G, Salaro C, Costa MC, Patterson JW, Nenoff P. Lymphogranuloma venereum: “a clinical and histopathological chameleon?”. An Bras Dermatol. 2010;85:525–30. DOIPubMedGoogle Scholar
- Bernstein DI, Hubbard T, Wenman WM, Johnson BL Jr, Holmes KK, Liebhaber H, et al. Mediastinal and supraclavicular lymphadenitis and pneumonitis due to Chlamydia trachomatis serovars L1 and L2. N Engl J Med. 1984;311:1543–6. DOIPubMedGoogle Scholar
- Oud EV, de Vrieze NH, de Meij A, de Vries HJ. Pitfalls in the diagnosis and management of inguinal lymphogranuloma venereum: important lessons from a case series. Sex Transm Infect. 2014;90:279–82. DOIPubMedGoogle Scholar
1Results from this study were presented as a poster at the IDWEEK 2017 Conference, October 4–8, 2017, San Diego, CA, USA. Abstracts of the IDWEEK 2017 Conference have been published in a supplement issue of Open Forum Infectious Diseases (https://idsa.confex.com/idsa/2017/webprogram/POSTER.html).
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.